Your session is about to expire
← Back to Search
Procedure
Peripheral Stem Cell Transplantation for Multiple Myeloma
Phase 2
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Non-Hodgkin's lymphoma with T-cell immunophenotypes included
Performance status Karnofsky 60-100%
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well peripheral stem cell transplantation works in treating patients with B-cell cancers.
Who is the study for?
This trial is for adults with B-cell cancers like multiple myeloma or lymphoma. Participants need a certain white blood cell and platelet count, heart function (LVEF) of at least 40%, good lung capacity, and can't be pregnant or have infections needing broad antibiotics. They must not have had chemotherapy, biologic, or endocrine therapy within the last 2 weeks.Check my eligibility
What is being tested?
The study is testing if high doses of chemotherapy followed by peripheral stem cell transplantation can effectively treat patients with multiple myeloma or other B-cell cancers. This phase II trial aims to see how well this approach works in killing cancer cells.See study design
What are the potential side effects?
High-dose chemotherapy can cause side effects such as nausea, hair loss, fatigue, increased risk of infection due to low blood counts, mouth sores, and potential damage to organs like the heart and lungs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My lymphoma is a type of T-cell non-Hodgkin's.
Select...
I can care for myself but may not be able to do active work.
Select...
I do not have an infection or fever that needs strong antibiotics.
Select...
I have been diagnosed with a specific type of blood cancer.
Select...
I am 18 years old or older.
Select...
My heart's pumping ability is at least 40%.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
604 Previous Clinical Trials
1,162,246 Total Patients Enrolled
23 Trials studying Lymphoma
4,343 Patients Enrolled for Lymphoma
David H. Vesole, MD, PhDStudy ChairMedical College of Wisconsin
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My lymphoma is a type of T-cell non-Hodgkin's.I can care for myself but may not be able to do active work.I do not have an infection or fever that needs strong antibiotics.I have been diagnosed with a specific type of blood cancer.It has been over 2 weeks since my last biologic therapy.My lung function tests are at least half of what's expected for someone my age and size.I am 18 years old or older.It's been over 2 weeks since my last hormone therapy.My heart's pumping ability is at least 40%.It's been over 2 weeks since my last chemotherapy and I've recovered.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this intervention obtained federal authorization?
"While Phase 2 trials lack information regarding the efficacy of a treatment, there is evidence indicating safety; thus it has been assessed as receiving a score of 2."
Answered by AI
Are there any opportunities to enroll in this research study at present?
"From the information presented on clinicaltrials.gov, it is evident that this particular trial has stopped recruiting participants as of January 3rd 2014. Initiated in September 1997 and now inactive, 2413 trials remain open for enrolment across the globe."
Answered by AI
Share this study with friends
Copy Link
Messenger